MRKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Marker Therapeutics Inc (MRKR) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is weak, with significant YoY declines in revenue, net income, and EPS. There are no positive trading trends, no recent news catalysts, and technical indicators suggest limited upside potential. Additionally, the stock's probability of decline in the short and medium term further supports a sell recommendation.
The MACD histogram is positive but contracting, indicating weakening momentum. RSI is neutral at 59.513, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock has a 60% chance of declining -4.64% in the next day, -4.5% in the next week, and -17.05% in the next month. Key support and resistance levels are Pivot: 1.54, R1: 1.739, S1: 1.341, R2: 1.861, S2: 1.219.
NULL identified. There is no recent news or significant trading trends to act as a positive catalyst.
Weak financial performance with YoY declines in revenue (-51.00%), net income (-55.62%), and EPS (-78.57%). The stock also has a high probability of short-term and medium-term decline based on candlestick pattern analysis.
In Q4 2025, revenue dropped to $1,103,444 (-51.00% YoY), net income dropped to -$1,703,210 (-55.62% YoY), and EPS dropped to -0.09 (-78.57% YoY). Gross margin remained flat at 100%. Overall, the financials indicate significant weakness.
No analyst rating or price target changes were provided.
